ArticleNature communications2019
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
Min Thura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papertrialcites it
ArticleNature communications2019
Min Thura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.